# Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects

> **NCT03563846** · PHASE1 · COMPLETED · sponsor: **Ritter Pharmaceuticals, Inc.** · enrollment: 14 (actual)

## Conditions studied

- Lactose Intolerance

## Interventions

- **DRUG:** RP-G28

## Key facts

- **NCT ID:** NCT03563846
- **Lead sponsor:** Ritter Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-09
- **Primary completion:** 2018-04-13
- **Final completion:** 2018-04-13
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2018-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03563846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03563846, "Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03563846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*